MONDAY, Oct. 7, 2024 (HealthDay News) -- A pair of American scientists have won the 2024 Nobel Prize in medicine for their ...

The Nobel Prize in medicine was awarded to Victor Ambros, PhD, of the University of Massachusetts, and Gary Ruvkun, PhD, of ...

A large team of microbiologists, pathologists and infectious diseases specialists affiliated with several institutions in the ...

Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...

In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

Two scientists who discovered a type of RNA molecule that helps control the activity of genes have won the 2024 Nobel Prize ...

Researchers found that SARS-CoV-2-specific plasma cells were largely excluded from the long-lived plasma cell compartment in ...

Moderna doses the first participant in a phase III study evaluating its mRNA norovirus vaccine candidate, mRNA-1403, in the ...

If scientists can better understand how they work and how to manipulate them, it could lead to powerful treatments for ...

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.

The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health ...

We recently compiled a list of 10 Worst Performing Stocks to Buy on the Dip. In this article, we will look at where Moderna, ...